| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 3.00 Billion | USD 10.84 Billion | 13.7% | 2024 |
FrequentlyAsked Questions
The global heart pump device market is expected to grow due to rising prevalence of cardiovascular diseases, growing adoption of minimally invasive procedures, and advancements in device technology.
According to a study, the global heart pump device market size was worth around USD 3.00 Billion in 2024 and is expected to reach USD 10.84 Billion by 2034.
The global heart pump device market is expected to grow at a CAGR of 13.7% during the forecast period.
North America is expected to dominate the heart pump device market over the forecast period.
Leading players in the global heart pump device market include Abbott Laboratories (US), Abiomed (US), Medtronic (Ireland), Teleflex Incorporated (US), SynCardia Systems (US), Fresenius Medical Care AG & Co. KGaA (Germany), Getinge (Sweden), CardiacAssist Inc (US), Berlin Heart (Germany), Jarvik Heart Inc (US), CARMA, among others.
The report explores crucial aspects of the heart pump device market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients